Common factors such as education, ethnicity, income, and marital status do not appear to be risk factors for the development of MDD. Instead, MDD often emerges subsequent to a significant ...

For the twenty-one million American adults experiencing major depressive disorder (MDD) annually, this FDA-cleared treatment ...

“Major depressive disorder” is another name for clinical ... It can take time to find a treatment plan that works, but many people find that their symptoms respond well to a combination ...

Major depressive disorder (MDD) is a chronic and recurrent ... of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant core ...

Minimally adequate treatment for major depressive disorders is defined as at least ... Organization's Comprehensive Mental Health Action Plan 2013–2030, which aims to increase mental health ...

A University of Queensland-led team analyzed data for 204 countries and territories, to assess global access to adequate ...

The CDC estimates that depression now impacts one in six American adults. After the newest numbers, ABC15 gets an up close ...

Relmada Therapeutics' depression treatment is "unlikely" to meet the main goal of a late-stage trial, it said on Wednesday, citing an independent data monitoring committee's analysis. The treatment, ...

Relmada is now scrapping Reliance II, plus another phase 3 trial called Relight, which was assessing REL-1017 as an add-on ...

Relmada Therapeutics lost more than two-thirds of its market value early Wednesday after the biotechnology company said a treatment for major depressive disorder would likely fail to meet its primary ...